Dr Rob Holgate

Rob has over 25 years’ experience in drug discovery and early-stage development. After obtaining his PhD in molecular medicine at UCL, he moved to The University of York as a post-doctoral researcher. He subsequently worked at Cambridge Antibody Technology before joining Antitope (now Abzena) in 2008 as Research Manager, then leading Abzena’s Discovery and Protein Engineering group. Now, as VP Research and Innovation, Rob plays a key role working with clients to understand the challenges they may face during discovery and early development to help them develop safe and effective therapies.